Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Development of a Wearable Carpal Arch Space Augmentation Device to Treat CTS | Grant | 100,000.00 | Research | Zong-Ming Li | Orthopedic Surgery | Flinn Foundation | 02/2025 |
| EIK1003-001 (IMP1734-101): A First-in-Human, Phase 1/2, Open-Label, Multicenter, Dose-Escalation, Dose-Optimization, and Dose-Expansion Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Ph | Contract | * | Clinical Trial | Alejandro Recio Boiles | Cancer Center Division | Eikon Therapeutics | 02/2025 |
| Global Health Equity Scholars Program | Grant | 56,688.00 | Research Training | Purnima Madhivanan | Global Health Institute | Yale University | 02/2025 |
| Inflammatory Bowel Disease (IBD) West Case Conference | Grant | 5,000.00 | Instruction | Sasha Taleban | Medicine | Boehringer Ingelheim Pharmaceuticals, Inc | 02/2025 |
| Investigator Studies Program (MISP): Vaccination Confidence | Grant | 350,008.75 | Research | Purnima Madhivanan | Health Promotion Sciences | Merck and Company | 02/2025 |
| Lupus Nexus Landmark Study: A Prospective Registry and Biorepository | Contract | * | Clinical Trial | Chian Kwoh | Arthritis Center-Research | Lupus Research Alliance, Inc | 02/2025 |
| MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis | Contract | * | Clinical Trial | Deepak Acharya | Sarver Heart Center | Medpace | 02/2025 |
| Mechanisms by Which Human Milk-Derived OligosaccharidesProtect Intestinal Barrier and Attenuate Inflammation | Grant | 107,210.00 | Research | Pawel Kiela | Pediatrics | Vanderbilt University Medical Center | 02/2025 |
| Microbiome and Nutrition in Severe PARDS | Grant | 142,299.00 | Research | Pawel Kiela | Pediatrics | Baylor College of Medicine | 02/2025 |
| Molecular Approach for Oropharyngeal Cancer Detection in Non-Plasma Biofluid | Grant | 99,863.50 | Research | Mark Nelson | Pathology and Lab Medicine | Flinn Foundation | 02/2025 |
| New Date. The First Accurate Due Date Predictor | Grant | 100,000.00 | Research | Elise Erickson | College of Nursing | Flinn Foundation | 02/2025 |
| Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis | Grant | 150,000.00 | Research | Michael Fallon | COM Phx Internal Medicine | FAKnostics, LLC | 02/2025 |
| Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer's Disease Risk | Grant | 58,820.00 | Research | Michael Grandner | Psychiatry | University of Utah | 02/2025 |
| Plant Exosomes (PEVs) for Cell and Gene Therapies | Contract | 97,898.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | HonorHealth | 02/2025 |
| Predictive Diagnostics for Immunomodulatory Therapy in Inflammatory and Fibrotic Disease | Grant | 100,000.00 | Research | Steven Goldman | Sarver Heart Center | Flinn Foundation | 02/2025 |
| Puentes de Salud: Bridging Mental Health Gaps for Santa Cruz Seniors | Contract | 100,000.00 | Other Sponsored Activity | Sheila Soto | Public Hlth Prac & Trans Rsch | Santa Cruz County, Arizona | 02/2025 |
| Ravulizumab To Protect Patients with Chronic Kidney Disease (CKD) From Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized | Contract | * | Clinical Trial | Toshinobu Kazui | Surgery | Alexion Pharmaceuticals, Incorporated | 02/2025 |
| Regenerating the Parkinson's Brain: Assessing the Effect of Allopregnanolone on Striatal Dopamine Transporters | Grant | 100,000.00 | Research | Roberta Brinton | UAHS Brain Science | Flinn Foundation | 02/2025 |
| State Opioid Response (SOR IV) | Grant | 3,017,621.00 | Research | Maria Manriquez-Sanchez | COM Phx Obstetrics&Gynecology | Arizona Health Care Cost Containment System | 02/2025 |
| Targeting Drug Resistance in the Bone Microenvironment Using a Novel PIM-PROTAC | Grant | 1,791,407.00 | Research | Noel Warfel | Cellular & Molecular Medicine | United States Army Medical Research Acquisition Activity | 02/2025 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.